Using Lean-Facilitation to Improve Quality of Hepatitis C Testing in Primary Care

被引:2
|
作者
Yakovchenko, Vera [1 ]
DeSotto, Kristine [2 ]
Drainoni, Mari-Lynn [1 ,3 ,4 ,5 ]
Lukesh, William [2 ]
Miller, Donald R. [1 ]
Park, Angela [2 ]
Shao, Qing [1 ]
Thornton, David J. [3 ,6 ]
Gifford, Allen L. [3 ,6 ]
机构
[1] Edith Nourse Rogers VA Med Ctr, Ctr Healthcare Org & Implementat Res CHOIR, Bedford, MA 01730 USA
[2] Dept Vet Affairs, Off Healthcare Transformat, Washington, DC USA
[3] Boston Univ, Sch Med, Sect Infect Dis, Boston, MA 02118 USA
[4] Boston Univ, Sch Med, Dept Med, Evans Ctr Implementat & Improvement Sci, Boston, MA USA
[5] Boston Univ, Sch Publ Hlth, Dept Hlth Law Policy & Management, Boston, MA USA
[6] VA Boston Healthcare Syst, West Roxbury, MA USA
关键词
implementation science; quality improvement; Lean; facilitation; veterans; hepatitis c; HEALTH-CARE; VIRUS-INFECTION; SUSTAINABILITY; INTERVENTIONS;
D O I
10.1007/s11606-020-06210-5
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BACKGROUND: Lean management has been successfully employed in healthcare to improve outcomes and efficiencies. Facilitation is increasingly being used to support evidence-based practice uptake in healthcare. However, while both Lean and Facilitation are used in healthcare quality improvement, limited research has explored their integration and the sustainability of their combined effects. Objective: To improve hepatitis C virus (HCV) screening rates among persons born between 1945 and 1965 through the design and evaluation of a multi-modal Lean-Facilitation intervention (LFI) for Department of Veterans Affairs primary care community clinics. DESIGN: We conducted a mixed methods quasi-experimental evaluation in eight clinics, guided by the integrated Promoting Action on Research Implementation in Health Services framework. PARTICIPANTS: We engaged regional and local leadership (N = 9), implemented our LFI with clinicians and staff (N = 68), and conducted summative interviews with participants (N = 13). INTERVENTION: The LFI included six implementation strategies: (1) external facilitation, (2) stakeholder engagement, (3) champion activation, (4) rapid process improvement sessions, (5) Plan-Do-Study-Act cycles, and (6) audit-feedback. MEASURES: The primary outcome was rate of new HCV screening among previously untested patients with a primary care visit. Using interrupted time series, we analyzed intervention and time effects on HCV testing rates, and administered organizational readiness surveys, conducted summative qualitative interviews, and tracked facilitation events. RESULTS:The LFI was associated with significant, immediate, and sustained increases in HCV testing. No change was detected at matched comparison clinics. Staff accepted the LFI and the philosophy of "bottom-up" solution development yet had mixed feedback on its appropriateness and feasibility. Enablers of implementation and early sustainment included lower satisfaction with baseline HCV testing processes and staff culture, while later sustainment was related to implementation climate support, measurement, and evaluation. CONCLUSIONS: High-reach and relatively low effort, but persistent intervention led to significant improvement in guideline-concordant HCV testing rates which were sustained.
引用
收藏
页码:349 / 357
页数:9
相关论文
共 50 条
  • [21] Identifying Practice Facilitation Delays and Barriers in Primary Care Quality Improvement
    Ye, Jiancheng
    Zhang, Renwen
    Bannon, Jennifer E.
    Wang, Ann A.
    Walunas, Theresa L.
    Kho, Abel N.
    Soulakis, Nicholas D.
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2020, 33 (05) : 655 - +
  • [22] Using Clinical Registries to Improve the Quality of Neurosurgical Care
    Asher, Anthony L.
    Parker, Scott L.
    Rolston, John D.
    Selden, Nathan R.
    McGirt, Matthew J.
    NEUROSURGERY CLINICS OF NORTH AMERICA, 2015, 26 (02) : 253 - +
  • [23] The Role of Primary Health Care in Hepatitis B Testing and Management: A Case Study
    Richmond, Jacqueline A.
    Sasadeusz, Joe
    Temple-Smith, Meredith
    JOURNAL OF COMMUNITY HEALTH, 2018, 43 (01) : 38 - 47
  • [24] Treatment of Hepatitis C by Primary Care Providers
    Rockey, Don
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (10) : 959 - 960
  • [25] Vertical transmission of hepatitis C: Testing and health-care engagement
    Reid, Sharon
    Day, Carolyn A.
    Bowen, David G.
    Minnis, Jeannie
    Ludlow, Joanne
    Jacobs, Sue
    Gordon, Adrienne
    Haber, Paul S.
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2018, 54 (06) : 647 - 652
  • [26] Practice Facilitation to Improve Diabetes Care in Primary Care: A Report From the EPIC Randomized Clinical Trial
    Dickinson, W. Perry
    Dickinson, L. Miriam
    Nutting, Paul A.
    Emsermann, Caroline B.
    Tutt, Brandon
    Crabtree, Benjamin F.
    Fisher, Lawrence
    Harbrecht, Marjie
    Gottsman, Allyson
    West, David R.
    ANNALS OF FAMILY MEDICINE, 2014, 12 (01) : 8 - 16
  • [27] Impact of electronic reminder systems on hepatitis C screening in primary care
    MacLean, C. D.
    Berger, C.
    Cangiano, M. L.
    Ziegelman, D.
    Lidofsky, S. D.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (08) : 939 - 944
  • [28] Emergency department targeted screening for hepatitis C does not improve linkage to care
    Houri, Inbal
    Horowitz, Noya
    Katchman, Helena
    Weksler, Yael
    Miller, Ofer
    Deutsch, Liat
    Shibolet, Oren
    WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (32) : 4878 - 4888
  • [29] Testing implementation facilitation of a primary care-based collaborative care clinical program using a hybrid type III interrupted time series design: a study protocol
    Midboe, Amanda M.
    Martino, Steve
    Krein, Sarah L.
    Frank, Joseph W.
    Painter, Jacob T.
    Chandler, Michael
    Schroeder, Allison
    Fenton, Brenda T.
    Troszak, Lara
    Erhardt, Taryn
    Kerns, Robert D.
    Becker, William C.
    IMPLEMENTATION SCIENCE, 2018, 13
  • [30] Methadone in primary care in France: Using evidence for action against hepatitis C
    Roux, P.
    Morel, A.
    Wolfe, D.
    Carrieri, P.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2019, 71 : 91 - 92